Nagaokakyo, Japan

Shigeru Sakuyama

This inventor holds 3 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1980-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Sakuyama. Retrieved from https://idiyas.com/inventor/shigeru-sakuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Nagaokakyo, JP (1980 - 1981)
  • Sakai-gun, JP (2009)

Company Filing History:


Years Active: 1980-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeru Sakuyama: Pioneering Innovations in Pharmaceutical Compounds

Introduction:

Shigeru Sakuyama, a talented inventor hailing from Nagaokakyo, Japan, has made significant strides in the field of pharmaceutical compounds. With a keen focus on improving medical treatments, Sakuyama has garnered recognition for his groundbreaking inventions and patented compounds.

Latest Patents:

Sakuyama's latest patents include the development of innovative compounds with a wide range of applications in neurology and prostaglandin analogues. One notable patent is the creation of branched carboxylic acid compounds that have shown promising results in enhancing astrocyte function, making them valuable for conditions such as brain infarction, Parkinson's disease, and Alzheimer's disease. Another patent highlights 15-cyclobutyl-trans-Δ2-prostaglandin analogues, known for their prostaglandin-like activities and potential therapeutic benefits in various health conditions.

Career Highlights:

Currently affiliated with Ono Pharmaceutical Co., Ltd., Sakuyama has demonstrated a strong commitment to advancing pharmaceutical research and development. His innovative approach to drug discovery has led to the successful creation of multiple patents that hold great promise for improving healthcare outcomes worldwide.

Collaborations:

Throughout his career, Sakuyama has collaborated with esteemed colleagues such as Masayasu Kurono and Hisao Nakai. Together, they have synergized their expertise to innovate and create novel pharmaceutical compounds that have the potential to positively impact patients' lives.

Conclusion:

In conclusion, Shigeru Sakuyama stands as a pioneer in the realm of pharmaceutical innovations, showcasing a remarkable dedication to developing novel compounds with significant therapeutic potential. His inventive spirit and collaborative efforts underscore his invaluable contributions to the field of healthcare and pharmaceuticals. With a track record of impactful patents and a commitment to pushing the boundaries of scientific discovery, Sakuyama continues to inspire advancements in medical treatments and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…